(Q38206571)

31 August 2017

title

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy (English)

1 reference

31 August 2017

1 reference

1 reference

Gerty Schreibelt

3

0 references

Jurjen Tel

object named as

Jurjen Tel

series ordinal

4

0 references

Ghaith Bakdash

series ordinal

1

object named as

Ghaith Bakdash

1 reference

31 August 2017

Inge Schreurs

2

1 reference

31 August 2017

language of work or name

1 reference

23 April 2014

1 reference

Expert Review of Clinical Immunology

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

915-926

1 reference

Immunobiology of dendritic cells

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Innate immunity: the virtues of a nonclonal system of recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Pattern recognition receptors and control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Cell biology of antigen processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Endocytosis mechanisms and the cell biology of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

The cell biology of cross-presentation and the role of dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Maturation of function in dendritic cells for tolerance and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

The nature of activatory and tolerogenic dendritic cell-derived signal II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic cells: cellular mediators for immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Harnessing human plasmacytoid dendritic cells as professional APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Deciphering the message broadcast by tumor-infiltrating dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Viral dsRNA-activated human dendritic cells produce IL-27, which selectively promotes cytotoxicity in naive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Immunogenicity of targeted lentivectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Antigen crosspresentation by human plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Tumoricidal activity of human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

CD56 marks human dendritic cell subsets with cytotoxic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human inflammatory dendritic cells induce Th17 cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

TLR-activated conventional DCs promote γ-secretase-mediated conditioning of plasmacytoid DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Mechanisms of cellular communication through intercellular protein transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Immune system: a double-edged sword in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Tumour-associated macrophages and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic cells: tools and targets for antitumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human plasmacytoid dendritic cells: from molecules to intercellular communication network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Interferon-α in acute myeloid leukemia: an old drug revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Vemurafenib for melanoma metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Surface molecules on stimulated plasmacytoid dendritic cells are sufficient to cross-activate resting myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

Differentiation of Inflammatory Dendritic Cells Is Mediated by NF- B1-Dependent GM-CSF Production in CD4 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.912561

10.1586/1744666X.2014.912561

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference